1. Home
  2. PRTA vs NECB Comparison

PRTA vs NECB Comparison

Compare PRTA & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$8.15

Market Cap

429.2M

Sector

Health Care

ML Signal

N/A

Logo NorthEast Community Bancorp Inc.

NECB

NorthEast Community Bancorp Inc.

N/A

Current Price

$28.22

Market Cap

392.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PRTA
NECB
Founded
2012
1934
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
429.2M
392.6M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
PRTA
NECB
Price
$8.15
$28.22
Analyst Decision
Buy
Buy
Analyst Count
7
2
Target Price
$21.40
★ $31.50
AVG Volume (30 Days)
★ 420.1K
50.0K
Earning Date
11-05-2026
10-22-2026
Dividend Yield
N/A
★ 3.55%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 2.25
Revenue
★ $814,000.00
N/A
Revenue This Year
$775.41
$2.26
Revenue Next Year
N/A
$18.16
P/E Ratio
★ N/A
$12.54
Revenue Growth
N/A
★ N/A
52 Week Low
$7.70
$19.96
52 Week High
$11.80
$30.50

Technical Indicators

Market Signals
Indicator
PRTA
NECB
Relative Strength Index (RSI) 45.82 42.58
Support Level $8.01 $25.83
Resistance Level $9.14 $28.94
Average True Range (ATR) 0.44 0.70
MACD -0.01 -0.19
Stochastic Oscillator 37.55 5.08

Price Performance

Historical Comparison
PRTA
NECB

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

About NECB NorthEast Community Bancorp Inc.

NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.

Share on Social Networks: